The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

The next RAMP-UP call is opening soon

Pipettering i labbskål foto Johan Persson

The second RAMP-UP call is coming soon. This EU-funded doctoral programme (Marie Skłodowska-Curie Actions-COFUND), coordinated by Lund University, invites researchers from all faculties to submit proposals for co-funded doctoral projects in regenerative medicine and advanced therapy medicinal products (ATMPs).

RAMP-UP welcomes project proposals from a broad range of disciplines, including experimental and clinical research, technology and engineering, health economics and health policy, ethics, law and regulation, and the social sciences.

Research leaders whose projects are selected will have the opportunity to:

  • receive EU funding of up to EUR 2,925 per month per doctoral student for up to 48 months, with remaining costs covered by the research leader
  • supervise outstanding doctoral students working across the entire ATMP value chain, from scientific discovery and technology development to clinical translation and commercialisation
  • collaborate with more than 30 partners across academia, healthcare, industry and regulatory authorities
  • be part of a strong international network that promotes collaboration between academia, industry and the public sector, and drives innovation.

Webinars about the call

Call opens: 15 October 2026.
Application deadline: 15 November 2026.
Programme start: August 2027.

What is RAMP-UP?

RAMP-UP stands for Regenerative Medicine and Advanced Therapy Medicinal Products United for PhD Excellence. It is an EU-funded doctoral programme (MSCA-COFUND) that brings together four leading European universities and more than 30 international partners. The programme trains the next generation of researchers and innovators in regenerative medicine and advanced therapies, including cell-, gene- and tissue-based medicinal products.